Serum anti-müllerian hormone (AMH) levels correlate with infrarenal aortic diameter in healthy older men: Is AMH acardiovascular hormone?

Journal of Endocrinology

Volumn 219, Issue 1, 2013, Pages 13-20

  Dennis, Nicola A ^a   Jones, Gregory T ^b   Chong, Yih Harng ^a   van Rij, Andre M ^b   McLennan, Ian S ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cardiovascular; Hormone action; Menopause; Testis

Indexed keywords

INHIBIN B; MUELLERIAN INHIBITING FACTOR;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; AORTA; ARTICLE; BODY SURFACE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONE BLOOD LEVEL; HUMAN; KIDNEY BLOOD VESSEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERTOLI CELL; VARICOSIS; ABDOMINAL AORTA; BLOOD; CARDIOVASCULAR; HISTOLOGY; HORMONE ACTION; MENOPAUSE; MIDDLE AGED; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; TESTIS; VERY ELDERLY;

CARDIOVASCULAR; HORMONE ACTION; MENOPAUSE; TESTIS;

AGED; AGED, 80 AND OVER; ANTI-MULLERIAN HORMONE; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; VARICOSE VEINS;

EID: 84884190647     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0125     Document Type: Article

References (33)

1. Aksglaede L, Sorensen K, Boas M, Mouritsen A, Hagen CP, Jensen RB, Petersen JH, Linneberg A, Andersson AM, Main KM et al. (2010). Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. Journal of Clinical Endocrinology andMetabolism 95, 5357-5364. (doi:10.1210/jc.2010-1207)
2. Appt SE, Chen H, Clarkson TB & Kaplan JR (2012). Premenopausal anti- Müllerian hormone concentration is associated with subsequent atherosclerosis. Menopause 19, 1353-1359. (doi:10.1097/gme. 0b013e31825b4fe2)
3. Barker DJ (1995). Fetal origins of coronary heart disease. BMJ 311, 171-174. (doi:10.1136/bmj.311.6998.171)
4. Cai J, Pardali E, Sanchez-Duffhues G & ten Dijke P (2012). BMP signaling in vascular diseases. FEBS Letters 586, 1993-2002. (doi:10.1016/j.febslet. 2012.04.030)
5. Catlin EA, Tonnu VC, Ebb RG, Pacheco BA, Manganaro TF, Ezzell RM, Donahoe PK & Teixeira J (1997). Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung. Endocrinology 138, 790-796. (doi:10.1210/en.138.2.790)
6. Chong YH, Campbell AJ, Farrand S & McLennan IS (2012). Anti-Müllerian hormone level in older women: detection of granulosa cell tumor recurrence. International Journal of Gynecological Cancer 22, 1497-1499. (doi:10.1097/IGC.0b013e318270ac69)
7. Chong YH, DennisNA,Connolly MJ, Teh R, Jones GT, van Rij AM,Farrand S, Campbell AJ & McLennan IS (2013). Elderly men have low levels of anti-Müllerian hormone and inhibin B, but with high interpersonal variation: a cross-sectional study of the Sertoli cell hormones in 615 community-dwelling men. PLoS ONE 8. e70967. (doi:10.1371/journal. pone.0070967)
8. Dennis NA (2012). Is anti-Müllerian hormone a hormone. PhD Thesis, Anatomy. Dunedin: University of Otago, New Zealand. (available at: http://hdl.handle.net/10523/2558).
9. Dennis NA, Houghton LA, Jones GT, van Rij AM, Morgan K &McLennan IS (2012). The level of serum anti-Müllerian hormone correlates with vitamin D status in men and women but not in boys. Journal of Clinical Endocrinology and Metabolism 97, 2450-2455. (doi:10.1210/jc. 2012-1213)
10. Forsen TJ, Eriksson JG, Osmond C & Barker DJ (2004). The infant growth of boys who later develop coronary heart disease. Annals of Medicine 36, 389-392. (doi:10.1080/07853890410028438)
11. GriesingerG, Dafopoulos K, BuendgenN,Cascorbi I,Georgoulias P, Zavos A, Messini CI & Messinis IE (2012). Elimination half-life of anti-Müllerian hormone. Journal of Clinical Endocrinology and Metabolism 97, 2160-2163. (doi:10.1210/jc.2012-1070)
12. Jones GT (2011) The pathohistology of abdominal aortic aneurysm. In Diagnosis, Screening and Treatment of Abdominal, Thoracoabdominal and Thoracic Aortic Aneurysms, p 414Ed. RT Grundmann. Rijeka, Croatia: InTech.
13. Kelsey TW, Wright P, Nelson SM, Anderson RA & Wallace WH (2011). A validated model of serum anti-Müllerian hormone from conception to menopause. PLoS ONE 6, e22024. (doi:10.1371/journal.pone. 0022024)
14. La Marca A, Broekmans FJ, Volpe A, Fauser BC & Macklon NS (2009). Anti-Müllerian hormone (AMH): what do we still need to know?. Human Reproduction 24, 2264-2275. (doi:10.1093/humrep/dep210)
15. Lederle FA, Johnson GR, Wilson SE, Gordon IL, Chute EP, Littooy FN, Krupski WC, Bandyk D, Barone GW, Graham LM et al. (1997). Relationship of age, gender, race, and body size to infrarenal aortic diameter. The Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Investigators. Journal of Vascular Surgery 26, 595-601. (doi:10.1016/S0741-5214(97)70057-0)
16. LeeMM,DonahoePK, HasegawaT, Silverman B, Crist GB, Best S, HasegawaY, Noto RA, Schoenfeld D & MacLaughlin DT (1996). Müllerian inhibiting substance in humans: normal levels from infancy to adulthood. Journal of Clinical Endocrinology and Metabolism 81, 571-576. (doi:10.1210/jc.81.2.571)
17. Lowery JW & de Caestecker MP (2010). BMP signaling in vascular development and disease. Cytokine & Growth Factor Reviews 21, 287-298. (doi:10.1016/j.cytogfr.2010.06.001)
18. MacLaughlin DT & Donahoe PK (2004). Sex determination and differentiation. New England Journal of Medicine 350, 367-378. (doi:10.1056/ NEJMra022784)
19. Morgan K, Dennis NA, Ruffman T, Bilkey DK & McLennan IS (2011). The stature of boys is inversely correlated to the levels of their Sertoli cell hormones: do the testes restrain the maturation of boys? PLoS ONE 6, e20533. (doi:10.1371/journal.pone.0020533)
20. Paivansalo MJ,Merikanto J, Jerkkola T, SavolainenMJ,RantalaAO,KaumaH, Lilja M, Reunanen YA, Kesaniemi A & Suramo I (2000). Effect of hypertension and risk factors on diameters of abdominal aorta and common iliac and femoral arteries in middle-aged hypertensive and control subjects: a cross-sectional systematic study with duplex ultrasound. Atherosclerosis 153, 99-106. (doi:10.1016/S0021- 9150(00)00374-9)
21. Pearce WH, Slaughter MS, LeMaire S, Salyapongse AN, Feinglass J, McCarthy WJ & Yao JS (1993). Aortic diameter as a function of age, gender, and body surface area. Surgery 114, 691-697.
22. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL et al. (2003). Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107, 499-511. (doi:10.1161/01.CIR. 0000052939.59093.45)
23. RicciM,MohapatraB,UrbiztondoA,BirusinghRJ,MorgadoM,RodriguezMM, Lincoln J & VattaM(2010). Differential changes in TGF-b/BMP signaling pathway in the right ventricularmyocardium of newborns with hypoplastic left heart syndrome. Journal of Cardiac Failure 16, 628-634. (doi:10.1016/j.cardfail.2010.03.007)
24. Rietzschel E & De Buyzere M (2012). High-sensitive C-reactive protein: universal prognostic and causative biomarker in heart disease? Biomarkers in Medicine 6, 19-34. (doi:10.2217/bmm.11.108)
25. Seifer DB, Baker VL & Leader B (2011). Age-specific serum anti-Müllerian hormone values for 17 120 women presenting to fertility centers within the United States. Fertility and Sterility 95 ,747-750. (doi:10.1016/ j.fertnstert.2010.10.011)
26. Sonesson B, Lanne T, Hansen F & Sandgren T (1994). Infrarenal aortic diameter in the healthy person. European Journal of Vascular Surgery 8, 89-95. (doi:10.1016/S0950-821X(05)80127-6)
27. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L,DesvarieuxM, Ebrahim S, FatarMet al. (2007). Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cardiovascular Diseases 23, 75-80. (doi:10.1159/000097034)
28. Vainas T, Lubbers T, Stassen FR, Herngreen SB, van Dieijen-Visser MP, Bruggeman CA, Kitslaar PJ & Schurink GW (2003). Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 107, 1103-1105. (doi:10.1161/01.CIR.0000059938.95404.92)
29. Visser JA, Schipper I, Laven JS & Themmen AP (2012). Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nature Reviews. Endocrinology 8, 331-341. (doi:10.1038/ nchembio.912)
30. WangPY, Koishi K,McGeachie AB, KimberM, Maclaughlin DT, Donahoe PK & McLennan IS (2005). Müllerian inhibiting substance acts as a motor neuron survival factor in vitro. PNAS 102, 16421-16425. (doi:10.1073/ pnas.0508304102)
31. Wang PY, Protheroe A, Clarkson AN, Imhoff F, Koishi K & McLennan IS (2009). Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior. PNAS 106 ,7203-7208. (doi:10.1073/pnas. 0902253106)
32. WittmannW&McLennan IS (2011). The male bias in the number of Purkinje cells and the size of the murine cerebellum may require Müllerian inhibiting substance/anti-Müllerian hormone. Journal of Neuroendocrinology 23, 831-838. (doi:10.1111/j.1365-2826.2011.02187.x)
33. Yeap BB, Hyde Z, Norman PE, Chubb SA & Golledge J (2010). Associations of total testosterone, sex hormone-binding globulin, calculated free testosterone, and luteinizing hormone with prevalence of abdominal aortic aneurysm in older men. Journal of Clinical Endocrinology and Metabolism 95, 1123-1130. (doi:10.1210/jc.2009-1696)